Work

S1170 Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 24-Month Interim Analysis of the Phase 3 ENVISION Randomized Clinical Trial

Year: 2021

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000778212.30789.ae

Authors: Herbert L. Bonkovsky, Paolo Ventura, Laurent Gouya, Paula Aguilera Peiró, D. Montgomery Bissell, Penelope E. Stein, Karl E. Anderson, Susana Monroy, David J. Kuter, Jeeyoung Oh, John J. Ko, Zhaowei Hua, Marianne T. Sweetser, Eliane Sardh

Institutions: Atrium Health Wake Forest Baptist, University of Modena and Reggio Emilia, Hospital Clínic de Barcelona, University of California, San Francisco, King's College Hospital, The University of Texas Medical Branch at Galveston, Instituto Nacional de Pediatria, Massachusetts General Hospital, Konkuk University Medical Center, Alnylam Pharmaceuticals (United States), Karolinska University Hospital

Language: English

Topic: Porphyrin Metabolism and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3209276134

Cites:

Cited by: 2

Related to: 10